ARTYX

ARTyx helps in developing an avant-garde RNA therapeutic platform for cancer treatment With a preliminary focus on breast cancer.

#SimilarOrganizations #Financial #More

ARTYX

Industry:
Medical Oncology Therapeutics

Status:
Active

Total Funding:
100 K USD


Similar Organizations

4-antibody-ag-logo

4-Antibody AG

4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.

not_available_image

Kosmos Biotherapeutics

Kosmos Biotherapeutics develops an astrobiological therapeutic platformย for the treatment of post-evolutionary diseases.

proviva-therapeutics-logo

Proviva Therapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

synergys-biotherapeutics-logo

Synergys Biotherapeutics

Synergys Biotherapeutics is an antibody therapeutics company that focuses on creating antibody fusion biotherapeutics for cancer treatment.

vybio-logo

Vybio

Vybio focuses on the research and development of new drugs for oncology and hepatitis B.

zytox-therapeutics-logo

Zytox Therapeutics

Zytox Therapeutics develops protein-based drugs for cancer treatment.

Investors List

harvard-ilab_image

Harvard Innovation Labs

Harvard Innovation Labs investment in Grant - ARTyx

More informations about "ARTyx"

linkstock.net © 2022. All rights reserved